Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Monica Giuliani"'
Autor:
Giovanni Carlo De Vincentiis, Maria Laura Panatta, Eugenio De Corso, Giulia Marini, Alessandra Bianchi, Monica Giuliani, Emanuela Sitzia, Filippo Maria Tucci
Publikováno v:
Acta Otorhinolaryngologica Italica, Vol 40, Iss 1, Pp 44-49 (2020)
Externí odkaz:
https://doaj.org/article/313dec523397470ca133674006b0f563
Autor:
Raymond S. W. Tsang, Dennis K. S. Law, Rosita De Paola, Maria Giuliani, Maria Stella, Jianwei Zhou, Saul Deng, Giuseppe Boccadifuoco, Marzia Monica Giuliani, Laura Serino
Publikováno v:
mSphere, Vol 5, Iss 2 (2020)
ABSTRACT The molecular epidemiology of culture-confirmed invasive meningococcal disease (IMD) in Canada from 2010 to 2014 was studied with an emphasis on serogroup B Neisseria meningitidis (MenB) isolates, including their predicted coverage by the 4C
Externí odkaz:
https://doaj.org/article/6b3e93bc5d6c4392827b8a03489a4380
Autor:
Giada Buffi, Bruno Galletti, Maria Stella, Daniela Proietti, Evita Balducci, Maria Rosaria Romano, Elena Mori, Monica Fabbrini, Marzia Monica Giuliani, Francesco Berti, Immaculada Margarit
Publikováno v:
mSphere, Vol 4, Iss 4 (2019)
ABSTRACT Group B Streptococcus (GBS) infections constitute a major cause of invasive disease during the first three months of life and an unmet medical need that could be addressed by maternal vaccination. The GBS capsular polysaccharides (CPSs) have
Externí odkaz:
https://doaj.org/article/cc73657a23bd4115914741b7c472452e
Autor:
Shamez Ladhani, Marzia Monica Giuliani, Alessia Biolchi, Mariagrazia Pizza, Kazim Beebeejaun, Jay Lucidarme, Jamie Findlow, Mary Ramsay, Ray Borrow
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 2, Pp 309-311 (2016)
Serum samples from children immunized with a meningococcal serogroup B vaccine demonstrated potent serum bactericidal antibody activity against the hypervirulent Neisseria meningitidis serogroup W strain circulating in England. The recent introductio
Externí odkaz:
https://doaj.org/article/a4ee63d0ed67439e99673d439bdec983
Autor:
Sara Tomei, Marco Costantini, Alessia Biolchi, Michele Pellegrini, Thembile Mzolo, Francesco Nieddu, Chiara Azzari, Laura Santini, Pavitra Keshavan, Maria Moriondo, Elena Mori, Alessandro Brozzi, Silvia Ricci, Margherita Bodini, Marzia Monica Giuliani
Publikováno v:
Human Vaccines & Immunotherapeutics. 17:1442-1449
An increase in invasive meningococcal disease (IMD) incidence was observed in Tuscany in 2015/2016, mainly due to hypervirulent clonal complex (cc) 11 strains. In a post-hoc analysis, we assessed b...
Autor:
Muhamed-Kheir Taha, Marzia Monica Giuliani, Mariagrazia Pizza, Angelika Banzhoff, Ray Borrow, Rafik Bekkat-Berkani
Publikováno v:
Journal of Infection. 81:862-872
Serogroup B meningococci (MenB) remain a prominent cause of invasive meningococcal disease (IMD). The protein-based multicomponent 4CMenB and the bivalent MenB-FHbp are the only currently available vaccines against MenB-caused IMD. Efficacy studies a
Autor:
Marzia Monica Giuliani, Eva Hong, Stefania Bambini, Sonia Budroni, Ana Paula Silva de Lemos, Ray Borrow, Muhamed-Kheir Taha, Brunella Brunelli, Philip Boucher, Maria Giuliani, Mariagrazia Pizza, Alessia Biolchi, Ulrich Vogel, Rino Rappuoli, Heike Claus, Jay Lucidarme, Maria Cecília Gorla, Sara Tomei
Publikováno v:
Infectious Diseases and Therapy
Introduction Invasive meningococcal disease (IMD) is an important public health concern. In developed countries, most IMD is caused by meningococcal serogroup B (MenB) and two protein-based MenB vaccines are currently available: the four-component va
Autor:
Alexander Domnich, Roberto Gasparini, Daniela Amicizia, Giuseppe Boccadifuoco, Marzia Monica Giuliani, Donatella Panatto
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
Development of the 4-component meningococcal serogroup B vaccine (4CMenB) has required new assays for the reliable evaluation of the expression and cross-reactivity of those specific antigen variants that are predicted to be targeted by bactericidal
Externí odkaz:
https://doaj.org/article/c974fb9ff75441b9a21518c7586c943e
Autor:
Ray Borrow, Daniela Toneatto, Laura Serino, Rita La Gaetana, Maria Giuliani, Xilian Bai, Elena Mori, Sara Tomei, Alessia Biolchi, Rosita De Paola, Marzia Monica Giuliani, Jay Lucidarme, Maria Stella, Mariagrazia Pizza
Publikováno v:
Human Vaccines & Immunotherapeutics
The Meningococcal Antigen Typing System (MATS) has been developed as an hSBA surrogate to evaluate potential coverage afforded by the 4-component meningococcal serogroup B vaccine (4CMenB: Bexsero, GSK). We investigated whether the lower value of MAT
Autor:
Davide Serruto, Theo P. Sloots, Michael D. Nissen, Giuseppe Boccadifuoco, Alessandro Muzzi, Duccio Medini, Marzia Monica Giuliani, Sarah Tozer, Rosita De Paola, Mariagrazia Pizza, David M. Whiley, Ray Borrow, Maria Stella, Helen V. Smith
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Meningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA), Ne